Demant A/S (WILYY) Stock Price, News & Analysis

Company Overview

Demant A/S is a Denmark‐based global leader in hearing health care, specializing in the development, manufacturing and distribution of hearing aids, diagnostic equipment and related services. Founded in 1904 by Hans Demant, the company has evolved from a local hearing aid maker into a diversified provider of hearing solutions and technologies. Its mission is to improve quality of life for people with hearing loss through innovation in hearing care and personal audio devices.

The company’s product portfolio includes advanced hearing aids marketed under brands such as Oticon, Bernafon and Sonic, as well as hearing implants through its Advanced Bionics subsidiary. In addition to personal hearing devices, Demant offers diagnostic and screening instruments—ranging from audiometers to tympanometers—under names such as Maico and Interacoustics. These tools are used by hearing care professionals worldwide for accurate diagnosis and fitting, ensuring patients receive tailored treatment plans.

With operations in over 130 countries and a network of subsidiaries, distributors and hearing care clinics, Demant serves markets across Europe, North America, Asia-Pacific, Latin America and the Middle East. The company has invested heavily in digital hearing care platforms and telehealth solutions, enabling remote fitting and follow-up services. Its hearing centers and retail outlets provide comprehensive end-to-end care, from initial hearing tests to device programming and ongoing support.

Demant is led by President and Chief Executive Officer Søren Nielsen, who assumed the role in 2021, and is supported by an executive leadership team overseeing research, manufacturing, sales and service operations. Corporate governance is provided by an independent board of directors, which guides the company’s strategic direction and ensures adherence to high standards of ethics and sustainability in all areas of business activity.

Key Stats

• Today's Range: $20.19 to $20.19
• 50-Day Range: $18.78 to $21.93
• 52-Week Range: $15.03 to $21.93
• Volume: 2 shs
• Average Volume: 30 shs
• Market Capitalization: $8.63 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Buy

WILYY Stock Analysis - Frequently Asked Questions

How have WILYY shares performed this year?

Demant A/S's stock was trading at $18.66 at the start of the year. Since then, WILYY shares have increased by 8.2% and is now trading at $20.19.

How do I buy shares of Demant A/S?

Shares of WILYY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 7/18/2025
• Next Earnings (Estimated): 8/12/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: MED PRODUCTS
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:WILYY
• Previous Symbol: NASDAQ:WILYY
• CIK: N/A
• Web: www.demant.com
• Phone: (453) 917-7300
• Fax: 45-3927-8900
• Employees: 22,639
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 1.29
• Current Ratio: 1.63
• Quick Ratio: 1.22

Sales & Book Value

• Annual Sales: $3.25 billion
• Price / Sales: 2.65
• Cash Flow: $0.95 per share
• Price / Cash Flow: 21.28
• Book Value: $3.16 per share
• Price / Book: 6.39

Miscellaneous

• Outstanding Shares: 427,590,000
• Free Float: N/A
• Market Cap: $8.63 billion
• Optionable: Not Optionable
• Beta: 0.98